Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 31-40 of 65

Page
per page
  1. Flavopiridol hydrochloride
    A8640 Flavopiridol hydrochloride
    Summary: CDK inhibitor, potent and selective
      ≥21.9 mg/mL
  2. LEE011
    A8641 LEE011
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.88 mg/mL
  3. R547
    A8642 R547
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/2/4 inhibitor,ATP-competitive
      Soluble in DMSO
  4. WHI-P180
    A8643 WHI-P180
    Summary: EGFR/Janus Kinase 3 inhibitor
      Soluble in DMSO
  5. AMG 925
    B3277 AMG 925
    Target: Cyclin-Dependent Kinases|FLT3
    Summary: FLT3/CDK4 inhibitor,potent and selective
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  6. LDC000067
    B4754 LDC000067
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK9 inhibitor, novel and highly specific
      insoluble in H2O; insoluble in EtOH; ≥18.52 mg/mL
  7. LY2857785
    B8002 LY2857785
    Summary: CDK9 inhibitor
  8. Ro 3306
    A8885 Ro 3306
     4 Citation
    Target: Cyclin-Dependent Kinases
    Summary: An ATP-competitive, potent CDK1 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.39 mg/mL
  9. Purvalanol A
    B4990 Purvalanol A
    Summary: potent, and cell-permeable CDK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.45 mg/mL
  10. AZD-5597
    B5926 AZD-5597
    Summary: Potent CDK inhibitor
      ≥1.82 mg/mL

Items 31-40 of 65

Page
per page